Long-Term Belatacept Exposure Maintains Efficacy and Safety at 5 Years: Results From the Long-Term Extension of the BENEFIT Study

Three-Year Outcomes From BENEFIT-EXT: A Phase III Study of Belatacept Versus Cyclosporine in Recipients of Extended Criteria Donor Kidneys

(2012) J. O. Medina Pestana et al.   AMERICAN JOURNAL OF TRANSPLANTATION

The Implications of Acute Rejection and Reduced Allograft Function on Health Care Expenditures in Contemporary US Kidney Transplantation

(2012) Adrian Gheorghian et al.   TRANSPLANTATION

The Relationship Between Kidney Function and Long-term Graft Survival After Kidney Transplant

(2011) Bertram L. Kasiske et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Three-Year Outcomes from BENEFIT, a Randomized, Active-Controlled, Parallel-Group Study in Adult Kidney Transplant Recipients

(2011) F. Vincenti et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Belatacept-Based Regimens Are Associated With Improved Cardiovascular and Metabolic Risk Factors Compared With Cyclosporine in Kidney Transplant Recipients (BENEFIT and BENEFIT-EXT Studies)

(2011) Yves Vanrenterghem et al.   TRANSPLANTATION

Associations of Renal Function at 1-Year After Kidney Transplantation With Subsequent Return to Dialysis, Mortality, and Healthcare Costs

(2011) Mark A. Schnitzler et al.   TRANSPLANTATION

Use of 12-Month Renal Function and Baseline Clinical Factors to Predict Long-Term Graft Survival

(2011) Mark A. Schnitzler et al.   TRANSPLANTATION

A Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT-EXT Study)

(2010) A. Durrbach et al.   AMERICAN JOURNAL OF TRANSPLANTATION

A Phase III Study of Belatacept-based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)

(2010) F. Vincenti et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Long-Term Renal Allograft Survival in the United States: A Critical Reappraisal

(2010) K. E. Lamb et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Slope of changes in renal function in the first year post-transplantation and one-yr estimated glomerular filtration rate together predict long-term renal allograft survival

(2010) Jianyong Wu et al.   CLINICAL TRANSPLANTATION

Belatacept-Based Regimens Versus a Cyclosporine A-Based Regimen in Kidney Transplant Recipients: 2-Year Results From the BENEFIT and BENEFIT-EXT Studies

(2010) Christian P. Larsen et al.   TRANSPLANTATION

Reducing De Novo Donor-Specific Antibody Levels during Acute Rejection Diminishes Renal Allograft Loss

(2009) M. J. Everly et al.   AMERICAN JOURNAL OF TRANSPLANTATION

MDRD-Estimated GFR at One Year Post-Renal Transplant Is a Predictor of Long-Term Graft Function

(2008) C.R. Lenihan et al.   RENAL FAILURE